- Home
- VRDN vs DCH Comparison
VRDN vs DCH Comparison
Compare VRDN & DCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | DCH |
|---|---|---|
| Founded | 2006 | 1994 |
| Country | United States | United States |
| Employees | N/A | 18000 |
| Industry | Medical Specialities | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | VRDN | DCH |
|---|---|---|
| Price | $14.18 | $5.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $35.46 | $10.50 |
| AVG Volume (30 Days) | 3.4M | ★ 3.6M |
| Earning Date | 05-07-2026 | 05-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,706,000.00 | N/A |
| Revenue This Year | $13.73 | $82.65 |
| Revenue Next Year | $279.00 | $4.20 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.76 | $5.07 |
| 52 Week High | $34.29 | $8.75 |
Technical Indicators
Market Signals| Indicator | VRDN | DCH |
|---|---|---|
| Relative Strength Index (RSI) | 24.61 | 45.08 |
| Support Level | $13.59 | $5.58 |
| Resistance Level | $19.42 | $5.86 |
| Average True Range (ATR) | 1.00 | 0.27 |
| MACD | 0.22 | 0.02 |
| Stochastic Oscillator | 15.67 | 26.43 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
About DCH Dauch Corporation Common Stock
Dauch Corp is a world-wide Tier 1 Automotive Supplier, Dauch designs, engineers and manufactures Driveline and Metal Forming technologies to support electric, hybrid and internal combustion vehicles.